Kieslichova E, Frankova S, Protus M, Merta D, Uchytilova E, Fronek J, Sperl J
Department of Anesthesiology and Intensive Care, Transplantcenter, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Department of Hepatogastroenterology, Transplantcenter, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Transplant Proc. 2018 Jan-Feb;50(1):192-197. doi: 10.1016/j.transproceed.2017.11.032.
Amanita phalloides poisoning is a potentially fatal cause of acute liver failure. The aim of this study was to analyze the impact of initial patients' characteristics and different treatment modalities on the outcome of patients with liver failure caused by Amanita poisoning.
We retrospectively evaluated 23 patients admitted to our center between July 2007 and August 2016.
Mean time interval between Amanita phalloides ingestion and the onset of gastrointestinal symptoms was 12.48 ± 9.88 hours and the interval between ingestion and hospital admission 26.26 ± 15.14 hours. The treatment was intiated by oral decontamination using activated charcoal followed by intravenous rehydration and high doses of intravenous N-acetylcysteine and silibinin. Fourteen patients (61%) underwent extracorporeal elimination method. Ten patients had plasmapheresis, 1 patient had hemoperfusion, and 5 patients had fractionated plasma separation and adsorption. Seven patients who met King's College Criteria were listed for urgent liver transplantation; one of them died before transplantation. Six patients underwent liver transplantation; the mean waiting time was 6.5 ± 12.0 days (range, 1-31 days). One patient died 2 months afterward. All 16 patients who did not meet King's College Criteria and received conservative treatment survived.
Our results documented a good prognostic value of standard King's College Criteria for indication of urgent liver transplantation in acute liver failure caused by Amanita phalloides poisoning. Fractionated plasma separation and adsorption may contribute to low mortality on the waiting list. Intensive care and extracorporeal elimination methods seem to be crucial points of the conservative treatment.
毒鹅膏中毒是急性肝衰竭的一个潜在致命原因。本研究的目的是分析初始患者特征和不同治疗方式对毒鹅膏中毒所致肝衰竭患者预后的影响。
我们回顾性评估了2007年7月至2016年8月间入住本中心的23例患者。
从摄入毒鹅膏到出现胃肠道症状的平均时间间隔为12.48±9.88小时,从摄入到入院的时间间隔为26.26±15.14小时。治疗首先采用活性炭进行口服洗胃,随后进行静脉补液,并给予高剂量静脉注射N - 乙酰半胱氨酸和水飞蓟宾。14例患者(61%)接受了体外清除方法。10例患者进行了血浆置换,1例患者进行了血液灌流,5例患者进行了选择性血浆分离吸附。7例符合国王学院标准的患者被列入紧急肝移植名单;其中1例在移植前死亡。6例患者接受了肝移植;平均等待时间为6.5±12.0天(范围1 - 31天)。1例患者在2个月后死亡。所有16例不符合国王学院标准且接受保守治疗的患者均存活。
我们的结果证明了标准国王学院标准对毒鹅膏中毒所致急性肝衰竭紧急肝移植指征具有良好的预后价值。选择性血浆分离吸附可能有助于降低等待名单上的死亡率。重症监护和体外清除方法似乎是保守治疗的关键点。